Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Orthofix Medical Inc has a consensus price target of $23.33 based on the ratings of 5 analysts. The high is $24 issued by Canaccord Genuity on February 26, 2025. The low is $22 issued by Roth MKM on February 26, 2025. The 3 most-recent analyst ratings were released by Canaccord Genuity, Roth MKM, and Canaccord Genuity on February 26, 2025, February 26, 2025, and January 22, 2025, respectively. With an average price target of $23.33 between Canaccord Genuity, Roth MKM, and Canaccord Genuity, there's an implied 45.29% upside for Orthofix Medical Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
02/26/2025 | Buy Now | 49.44% | Canaccord Genuity | Caitlin Burrows49% | $24 → $24 | Maintains | Buy | Get Alert |
02/26/2025 | Buy Now | 36.99% | Roth MKM | Jason Wittes53% | $22 → $22 | Reiterates | Buy → Buy | Get Alert |
01/22/2025 | Buy Now | 49.44% | Canaccord Genuity | Caitlin Burrows49% | → $24 | Initiates | → Buy | Get Alert |
11/08/2024 | Buy Now | 36.99% | Roth MKM | Jason Wittes53% | $20 → $22 | Reiterates | Buy → Buy | Get Alert |
11/08/2024 | Buy Now | 49.44% | Stifel | Mathew Blackman61% | $18 → $24 | Upgrade | Hold → Buy | Get Alert |
05/08/2024 | Buy Now | 24.53% | Roth MKM | Jason Wittes53% | $15 → $20 | Upgrade | Neutral → Buy | Get Alert |
04/22/2024 | Buy Now | — | JMP Securities | David Turkaly53% | — | Reiterates | → Market Perform | Get Alert |
03/07/2024 | Buy Now | -6.6% | Roth MKM | Jason Wittes53% | $12 → $15 | Maintains | Neutral | Get Alert |
11/09/2023 | Buy Now | -12.83% | Stifel | Mathew Blackman61% | $16 → $14 | Maintains | Hold | Get Alert |
10/20/2023 | Buy Now | -25.28% | Roth MKM | Jason Wittes53% | → $12 | Initiates | → Neutral | Get Alert |
09/12/2023 | Buy Now | — | BTIG | Ryan Zimmerman73% | — | Downgrade | Buy → Neutral | Get Alert |
09/12/2023 | Buy Now | -0.37% | Stifel | Mathew Blackman61% | $30 → $16 | Downgrade | Buy → Hold | Get Alert |
07/19/2023 | Buy Now | 68.12% | BTIG | Ryan Zimmerman73% | → $27 | Reinstates | → Buy | Get Alert |
The latest price target for Orthofix Medical (NASDAQ:OFIX) was reported by Canaccord Genuity on February 26, 2025. The analyst firm set a price target for $24.00 expecting OFIX to rise to within 12 months (a possible 49.44% upside). 7 analyst firms have reported ratings in the last year.
The latest analyst rating for Orthofix Medical (NASDAQ:OFIX) was provided by Canaccord Genuity, and Orthofix Medical maintained their buy rating.
The last upgrade for Orthofix Medical Inc happened on November 8, 2024 when Stifel raised their price target to $24. Stifel previously had a hold for Orthofix Medical Inc.
The last downgrade for Orthofix Medical Inc happened on September 12, 2023 when BTIG changed their price target from N/A to N/A for Orthofix Medical Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Orthofix Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Orthofix Medical was filed on February 26, 2025 so you should expect the next rating to be made available sometime around February 26, 2026.
While ratings are subjective and will change, the latest Orthofix Medical (OFIX) rating was a maintained with a price target of $24.00 to $24.00. The current price Orthofix Medical (OFIX) is trading at is $16.06, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.